Published in J Clin Sleep Med on January 15, 2015
Developing Biomarker Arrays Predicting Sleep and Circadian-Coupled Risks to Health. Sleep (2016) 0.90
Effects of adenotonsillectomy on plasma inflammatory biomarkers in obese children with obstructive sleep apnea: A community-based study. Int J Obes (Lond) (2015) 0.84
Development of a Brief Pre-Implementation Screening Tool to Identify Teachers Who Are at Risk for Not Implementing Intervention Curriculum and High-Implementing Teachers. Health Educ Behav (2016) 0.75
Sleep Apnea: Types, Mechanisms, and Clinical Cardiovascular Consequences. J Am Coll Cardiol (2017) 0.75
Evolve Sleep: Optimized Solutions To Help Your Sleep Medicine Practice Thrive. J Clin Sleep Med (2015) 0.75
Urinary biomarkers and obstructive sleep apnea in patients with Down syndrome. Sleep Med (2017) 0.75
The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews. BMC Med Res Methodol (2003) 16.17
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg (2010) 12.98
The diagnostic odds ratio: a single indicator of test performance. J Clin Epidemiol (2003) 7.54
Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation (2002) 4.77
Epidemiology of pediatric obstructive sleep apnea. Proc Am Thorac Soc (2008) 3.33
Increased 8-isoprostane and interleukin-6 in breath condensate of obstructive sleep apnea patients. Chest (2002) 3.05
Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation (2003) 2.98
Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics (2012) 2.75
Sleep duration and biomarkers of inflammation. Sleep (2009) 2.73
The association of oxidative stress with central obesity in obstructive sleep apnea. Sleep Breath (2011) 2.19
Cysteine: a potential biomarker for obstructive sleep apnea. Chest (2010) 2.19
Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep (2009) 2.11
Serum levels of vascular endothelial growth factor are elevated in patients with obstructive sleep apnea and severe nighttime hypoxia. Am J Respir Crit Care Med (2002) 2.08
Variation of C-reactive protein levels in adolescents: association with sleep-disordered breathing and sleep duration. Circulation (2005) 1.99
Effects of nasal continuous positive airway pressure on soluble cell adhesion molecules in patients with obstructive sleep apnea syndrome. Am J Med (2000) 1.96
DNA methylation in inflammatory genes among children with obstructive sleep apnea. Am J Respir Crit Care Med (2011) 1.92
Plasma C-reactive protein levels among children with sleep-disordered breathing. Pediatrics (2004) 1.88
C-reactive protein is associated with sleep disordered breathing independent of adiposity. Sleep (2007) 1.79
Cross-cultural comparison of the sleep-disordered breathing prevalence among Americans and Japanese. Eur Respir J (2010) 1.79
Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath (2006) 1.76
Effects of continuous positive airway pressure therapy withdrawal in patients with obstructive sleep apnea: a randomized controlled trial. Am J Respir Crit Care Med (2011) 1.71
Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol (2005) 1.70
Nocturnal pulse oximetry as an abbreviated testing modality for pediatric obstructive sleep apnea. Pediatrics (2000) 1.69
C-reactive protein, obstructive sleep apnea, and cognitive dysfunction in school-aged children. Am J Respir Crit Care Med (2007) 1.68
Obstructive sleep apnea: a cardiometabolic risk in obesity and the metabolic syndrome. J Am Coll Cardiol (2013) 1.65
Oxidative stress in obstructive sleep apnea. Chest (2005) 1.65
Interleukin-6 and tumor necrosis factor-alpha in patients with obstructive sleep apnea-hypopnea syndrome. Respiration (2004) 1.63
Systemic inflammation in non-obese children with obstructive sleep apnea. Sleep Med (2007) 1.58
Plasminogen activator inhibitor-1 in obstructive sleep apnea patients with and without hypertension. Lung (2008) 1.55
Association of elevated levels of vascular endothelial growth factor in obstructive sleep apnea syndrome with patient age rather than with obstructive sleep apnea syndrome severity. Respiration (2006) 1.50
Neurocognitive impairment in obstructive sleep apnea. Chest (2012) 1.50
Lectin-like oxidized low-density lipoprotein receptor-1 modulates endothelial apoptosis in obstructive sleep apnea. Chest (2011) 1.44
Advanced heart failure and nocturnal hypoxaemia due to central sleep apnoea are associated with increased serum erythropoietin. Eur J Heart Fail (2010) 1.44
C-reactive protein and sleep-disordered breathing. Sleep (2004) 1.41
Effects of obstructive sleep apnea on circulating ICAM-1, IL-8, and MCP-1. J Appl Physiol (1985) (2002) 1.38
C-reactive protein is associated with obstructive sleep apnea independent of visceral obesity. Chest (2009) 1.32
Inflammatory mediators in exhaled breath condensate of children with obstructive sleep apnea syndrome. Chest (2006) 1.31
Plasma C-reactive protein in nonobese children with obstructive sleep apnea before and after adenotonsillectomy. J Clin Sleep Med (2006) 1.29
The effect of short-term withdrawal from continuous positive airway pressure therapy on sympathetic activity and markers of vascular inflammation in subjects with obstructive sleep apnoea. J Sleep Res (2007) 1.19
Sleep apnea predicts distinct alterations in glucose homeostasis and biomarkers in obese adults with normal and impaired glucose metabolism. Cardiovasc Diabetol (2010) 1.19
Plasma adhesion molecules in children with sleep-disordered breathing. Chest (2006) 1.13
Two-dimensional differential in-gel electrophoresis proteomic approaches reveal urine candidate biomarkers in pediatric obstructive sleep apnea. Am J Respir Crit Care Med (2009) 1.13
Exhaled breath markers in patients with obstructive sleep apnoea. Sleep Breath (2007) 1.12
Sleep measures and morning plasma TNF-alpha levels in children with sleep-disordered breathing. Sleep (2010) 1.11
Soluble interleukin 6 receptor: A novel marker of moderate to severe sleep-related breathing disorder. Arch Intern Med (2006) 1.11
Circulating vascular endothelial growth factor levels in patients with obstructive sleep apnea. Sleep (2002) 1.11
Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) (2006) 1.11
Adiponectin as a routine clinical biomarker. Best Pract Res Clin Endocrinol Metab (2013) 1.10
Roles of gender, age, race/ethnicity, and residential socioeconomics in obstructive sleep apnea syndromes. Curr Opin Pulm Med (2012) 1.10
Adhesion molecules in patients with coronary artery disease and moderate-to-severe obstructive sleep apnea. Chest (2002) 1.09
Serum aminotransferase levels are associated with markers of hypoxia in patients with obstructive sleep apnea. Sleep (2008) 1.08
Adipokines in children with sleep disordered breathing. Sleep (2007) 1.08
Cardiovascular risk markers in obstructive sleep apnoea syndrome and correlation with obesity. Thorax (2007) 1.06
Increased cellular proliferation and inflammatory cytokines in tonsils derived from children with obstructive sleep apnea. Pediatr Res (2009) 1.05
Antioxidant capacity in obstructive sleep apnea patients. Sleep Med (2003) 1.05
Continuous positive airway pressure therapy improves vascular dysfunction and decreases oxidative stress in patients with the metabolic syndrome and obstructive sleep apnea syndrome. Clin Cardiol (2012) 1.05
Circulating adropin concentrations in pediatric obstructive sleep apnea: potential relevance to endothelial function. J Pediatr (2013) 1.05
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging (2013) 1.04
Plasma vascular endothelial growth factor in sleep apnea syndrome: effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med (2002) 1.04
Pituitary reactivity, androgens and catecholamines in obstructive sleep apnoea. Effects of continuous positive airway pressure treatment (CPAP). Respir Med (1999) 1.01
Obstructive sleep apnea in children: a critical update. Nat Sci Sleep (2013) 1.00
The relationship between high-sensitivity C-reactive protein levels and the severity of obstructive sleep apnea. Sleep Breath (2011) 1.00
Insulin and obstructive sleep apnea in obese Chinese children. Pediatr Pulmonol (2006) 0.99
Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol (2009) 0.99
Serum, urine, and breath-related biomarkers in the diagnosis of obstructive sleep apnea in children: is it for real? Curr Opin Pulm Med (2012) 0.99
Inflammatory markers in middle-aged obese subjects: does obstructive sleep apnea syndrome play a role? Mediators Inflamm (2010) 0.98
Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressure. Arch Med Sci (2011) 0.98
Lipid peroxides, superoxide dismutase and circulating IL-8 and GCP-2 in patients with severe obstructive sleep apnea: a pilot study. Sleep Breath (2005) 0.97
CPAP decreases plasma levels of soluble tumour necrosis factor-alpha receptor 1 in obstructive sleep apnoea. Eur Respir J (2008) 0.97
Peripheral blood leukocyte gene expression patterns and metabolic parameters in habitually snoring and non-snoring children with normal polysomnographic findings. Sleep (2011) 0.97
Lipopolysaccharide-binding protein plasma levels in children: effects of obstructive sleep apnea and obesity. J Clin Endocrinol Metab (2013) 0.95
C-reactive protein in children with obstructive sleep apnea and the effects of treatment. Pediatr Pulmonol (2008) 0.95
Effect of an ambulatory diagnostic and treatment programme in patients with sleep apnoea. Eur Respir J (2011) 0.94
Urinary protein expression patterns in children with sleep-disordered breathing: preliminary findings. Sleep Med (2006) 0.94
Circulating ICAM-1 and VCAM-1 levels in patients with obstructive sleep apnea syndrome. Respiration (2006) 0.94
Urinary concentration of 8-isoprostane as marker of severity of pediatric OSAS. Sleep Breath (2014) 0.94
Tumor necrosis factor-alpha expression in uvular tissues differs between snorers and apneic patients. Chest (2008) 0.93
Myeloid-related protein 8/14 levels in children with obstructive sleep apnoea. Eur Respir J (2009) 0.93
Increased serum levels of C-reactive protein and matrix metalloproteinase-9 in obstructive sleep apnea syndrome. Chin Med J (Engl) (2007) 0.93
Systematic review on noninvasive assessment of subclinical cardiovascular disease in obstructive sleep apnea: new kid on the block! Sleep Med Rev (2014) 0.92
Obstructive sleep apnea and cardiovascular disease: evidence and underlying mechanisms. Minerva Pneumol (2009) 0.92
TREM-1 and pentraxin-3 plasma levels and their association with obstructive sleep apnea, obesity, and endothelial function in children. Sleep (2013) 0.91
Levels of thioredoxin are related to the severity of obstructive sleep apnea: based on oxidative stress concept. Sleep Breath (2012) 0.91
Comparison of serum adiponectin and tumor necrosis factor-alpha levels between patients with and without obstructive sleep apnea syndrome. Respiration (2008) 0.90
Screening of pediatric sleep-disordered breathing: a proposed unbiased discriminative set of questions using clinical severity scales. Chest (2012) 0.88
Circulating microparticles from obstructive sleep apnea syndrome patients induce endothelin-mediated angiogenesis. Biochim Biophys Acta (2013) 0.88
Oxidative stress in patients with obstructive sleep apnea syndrome. Sleep Breath (2012) 0.88
Screening obstructive sleep apnoea syndrome by home videotape recording in children. Eur Respir J (1996) 0.88
Plasma thioredoxin, a novel oxidative stress marker, in patients with obstructive sleep apnea before and after nasal continuous positive airway pressure. Antioxid Redox Signal (2008) 0.88
Cytokine changes after surgical treatment of obstructive sleep apnoea syndrome. Eur Arch Otorhinolaryngol (2008) 0.87
Exhaled breath condensate cytokine level as a diagnostic tool for obstructive sleep apnea syndrome. Sleep Med (2008) 0.87
Urinary F2-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath (2006) 0.87
Oxidative stress and inflammatory markers in the exhaled breath condensate of children with OSA. Sleep Breath (2011) 0.87
Urine concentrations of cysteinyl leukotrienes in children with obstructive sleep-disordered breathing. Chest (2009) 0.87
Adipokines in children with obstructive sleep apnea and the effects of treatment. Chest (2009) 0.87
Can red blood cell distribution width predict severity of obstructive sleep apnea syndrome? J Clin Sleep Med (2012) 0.86
Relationship of oxidative stress and endothelial dysfunction in sleep apnoea. Eur Respir J (2010) 0.86
Fatty-acid binding protein 4 gene polymorphisms and plasma levels in children with obstructive sleep apnea. Sleep Med (2011) 0.86
S100B and NSE serum levels in obstructive sleep apnea syndrome. Sleep Med (2006) 0.86
Biomarkers associated with obstructive sleep apnea: A scoping review. Sleep Med Rev (2014) 0.97